
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
For Contemporary Pediatrics, Dr Bobby Lazzara explains key findings from a randomized, double-blind trial published in Clinical Gastroenterology and Hepatology. The study examined whether psyllium fiber could provide nonmedical relief to children and teenagers suffering from IBS.
For Contemporary Pediatrics, Dr Bobby Lazzara explains key findings from a randomized, double-blind trial published in Clinical Gastroenterology and Hepatology. The study examined whether psyllium fiber could provide nonmedical relief to children and teenagers suffering from IBS.






